Free & Fearless Press – Right of every Indian
Ranbaxy Laboratories declared the results for the quarter ended March ’09 and held a tele conference call on 24th April’09 to discuss the financial performance as well as future plans. The key takeaways from the meet are as follows: Consolidated net sales for the quarter declined by 4% to Rs 1558.4 crore due to poor … Read more Ranbaxy Laboratories Expects revenue of Rs 7000 crore
Federal Bank is currently trading at Rs 189.70,up by 11.75 points or 6.60% from its previous closing on the BSE. The scrip opened at Rs 182 and has touched a high of Rs 189.80 with low remaining its opening price. So far 11,280 shares were traded on the BSE. The BSE group ‘A’ Bankex stock … Read more Federal Bank upbeat on merger talk with Catholic Syrian Bank
Crude prices gained for the third day in a row on Friday, despite contracting global demand and a huge reserves position. Worries that the US bank bailout will induce a wave of inflation sent money flowing into hard assets like oil. Benchmark crude for June delivery rose $1.93 to settle at $51.55 a barrel on … Read more Crude Speculators drive to $51.55 a barrel despite contracting demand
LIC Housing Finance (LHF) held its conference call on 24th April 2009 to discuss its Q4FY09 and FY09 results. Highlights LHF reported 30% growth in Income from operations to Rs 790.48 crore. With higher rise in interest expenses, the gross profit recorded a restricted growth of 21% to Rs 218.59 crore. The Net profit for … Read more LIC Housing Finance – Expects 25% growth in disbursements in FY10
Highlights of the call The company’s sales for the quarter ended March 09 has increased by 31% to Rs 539.37 crore, supported by volume growth in Horlick by 21% and Boost by 8%. There was a overall volume growth of 20%. There was a price growth of around 7% for the quarter. A 3% excise … Read more GlaxoSmithkline Consumer Healthcare – Margin will be around 18%
Piramal Healthcare posted 9% growth in net sales to Rs 850.91 crore for the quarter ended March 2009. Operating Profit margins crashed by 650 bps to 21.0% on the back of R & D expenses of Rs 20.18 crore as against R & D income of Rs 40.48 crore in the corresponding pervious period. Resulting … Read more Piramal Healthcare – Expects a revenue growth of 16-17% for FY’10